C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
12/2009
12/01/2009	US7626003 Genetically engineered cDNA of rat bcl-x gene and an improved protein
12/01/2009	US7626002 Cytokine zalpha11 ligand antibodies
12/01/2009	US7625756 Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells
12/01/2009	US7625751 WNV core protein/capsid interacting protein and uses of the same
12/01/2009	US7625732 Isolated DNA encoding cullin regulators ROC1 and ROC2, isolated proteins encoded by the same, and methods utilizing the same
12/01/2009	US7625725 Provides novel extracts, proteins, and complexes that improve the polymerization activity of nucleic acid polymerases; specifically described is nucleotide and amino acid sequence information for Pyrococcus furiousus PEF (P45), which was used to produce a recombinant PEF
12/01/2009	US7625721 Strip carrier system in which compression carrier applies to strip is accurately controlled, permitting more accurate control of flow of fluid through strip and, thus, improving repeatability and accuracy of test; manufacturing system efficiently assembles test strip assembly without handling by humans
12/01/2009	US7625717 Provides eukaryotic cells with translation components, e.g., pairs of orthogonal aminoacyl-tRNA synthetases and orthogonal tRNAs and individual components thereof, used in eukaryotic protein biosynthetic machinery to incorporate an unnatural amino acid in a growing polypeptide chain in a eukaryotic cell
12/01/2009	US7625710 Methods for determining 2F1-binding compounds
12/01/2009	US7625700 In vivo library-versus-library selection of optimized protein-protein interactions
12/01/2009	US7625569 Vaccines; fusion protein; induce immunology response
12/01/2009	US7625566 Monoclonal antibody for use as tool in prevention and treatment of viral disease; viricides
12/01/2009	US7625555 Recombinant human interferon-like proteins
12/01/2009	CA2298956C Genetically engineered cell culture adapted infectious bursal diseases virus (ibdv) mutants
12/01/2009	CA2208503C Recombinant il-5 antagonists useful in treatment of il-5 mediated disorders
12/01/2009	CA2107513C Fusion protein for prodrug activation
11/2009
11/26/2009	WO2009143332A2 Poultry viral materials and methods related thereto
11/26/2009	WO2009143041A1 Efficient production of heterologous proteins using mannosyl transferase inhibitors
11/26/2009	WO2009142441A2 Method for producing corn gluten hydrolysate and corn gluten hydrolysate using the same
11/26/2009	WO2009142352A1 Method of producing clostridium botulinum toxin using media containing plant-derived components and flexible closed container
11/26/2009	WO2009142307A1 Peptide capable of extending half-life of peptide of interest in plasma
11/26/2009	WO2009142221A1 Antibody capable of discriminating the change in structure between antibody conjugated with antibody and antibody unconjugated with antibody, and method for production of the antibody
11/26/2009	WO2009141458A1 Antibody specific for propionylated/butyrylated lysine, method for obtaining same and uses thereof
11/26/2009	WO2009140833A1 Collagen peptide having immunoenchancing activity from cyanea nozakii and preparation method and uses thereof
11/26/2009	WO2009140795A1 A method and kit for purification of recombinant proteins using a self-cleaving ptotein intein
11/26/2009	US20090292112 provide polypeptides inter alia that have been identified as novel proteins with homology to the Mindin family of extracellular matrix proteins (RG1); prostate cancer or benign prostatic hyperplasia, which is alleviated by decreasing the level of RG1 activity
11/26/2009	US20090292110 Enzymatic modification of glycopeptides
11/26/2009	US20090291892 SlpA as a tool for recombinant protein and enzyme technology
11/26/2009	US20090291888 Modulators of tnf receptor associated factor (traf), their preparation and use
11/26/2009	US20090291495 Neural Cell Populations from Primate Pluripotent Stem Cells
11/26/2009	US20090291473 Method for Production of Recombinant Human FSH
11/26/2009	US20090291472 Influenza nucleic acids, polypeptides, and uses thereof
11/26/2009	US20090291471 Novel Beta-Galactoside Alpha 2,6-Sialyltransferase, Gene Coding For The Transferase And Process For Producing The Same
11/26/2009	US20090291470 Chondroitin synthase, method for producing the same and method for producing saccharide chain-extended chondroitin
11/26/2009	US20090291469 Compositions and Methods for Producing Fermentation Products and Residuals
11/26/2009	US20090291459 Hybridoma capable of producing anti-dectin-1 monoclonal antibody
11/26/2009	US20090291455 Cynomolgus gp80 Receptor and Uses
11/26/2009	US20090291100 Therapeutic agent for polycystic ovary syndrome (pcos)
11/26/2009	US20090291097 IL-17 homologous polypeptides and therapeutic uses thereof
11/26/2009	US20090291094 Antibodies and processes for preparing the same
11/26/2009	US20090291090 Anti-cd33 antibodies and method for treatment of acute myeloid leukemia using the same
11/26/2009	US20090291084 Anti- il-6 antibodies, compositions, methods and uses
11/26/2009	US20090291081 Dual-specific IL-1A/IL-1b antibodies
11/26/2009	US20090291078 Glyco-engineered antibodies
11/26/2009	CA2723618A1 Antibody capable of discriminating the change in structure between antibody conjugated with antibody and antibody unconjugated with antibody, and method for production of the antibody
11/26/2009	CA2721459A1 Efficient production of heterologous proteins using mannosyl transferase inhibitors
11/26/2009	CA2698582A1 Peptide having an extending action for half-life of object peptide in plasma
11/26/2009	CA2667177A1 Slpa as a tool for recombinant protein and enzyme technology
11/25/2009	EP2123756A1 Transglutaminase having disulfide bond introduced therein
11/25/2009	EP2123751A1 Novel peptide
11/25/2009	EP2123746A2 Gene inactivated mutants with altered protein production
11/25/2009	EP2123677A1 Anti-brak (cxcl14) human monoclonal antibody and use thereof
11/25/2009	EP2123671A1 Immunogenic peptide composition for the prevention and treatment of Alzheimer's Disease
11/25/2009	EP2121958A1 Microbial process for production of enzymes
11/25/2009	EP2121752A1 Method for increasing protein yields
11/25/2009	EP2121725A1 C-terminal attachment of two chemical groups to peptides
11/25/2009	EP1861420B1 Fermentation process for the production of diphtheria toxin
11/25/2009	EP1658373B1 Co-expression vector for the membrane domains of viral envelope proteins and uses thereof
11/25/2009	EP1599595B1 N -acetylglucosaminyltransferase iii expression in lower eukaryotes
11/25/2009	EP1268509B1 Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof
11/25/2009	EP0954585B1 Human telomerase reverse transcriptase promoter
11/25/2009	CN101589155A Enzyme production in culture medium comprising raw glycerol
11/25/2009	CN101589146A Method for methanol independent induction from methanol inducible promoters in pichia
11/25/2009	CN101589059A Pharmaceutical composition comprising anti-HB-EGF antibody as active ingredient
11/25/2009	CN101589058A Cancer therapeutic agent comprising anti-HB-EGF antibody as active ingredient
11/25/2009	CN101586139A Method of extracting scale collagen polypeptide by microwave-assisted enzyme
11/25/2009	CN101586138A Process for preparing and purifying Exendin-4 from colon bacillus
11/25/2009	CN101586112A Gene cluster for biological synthesis of Nosiheptide
11/25/2009	CN101585881A An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/25/2009	CN101584860A Recombinant human Claudin18.2 tumor vaccine and preparation method thereof
11/25/2009	CN100562576C Method for producing secretion expression recombinant human fibroblast growth factor-21
11/24/2009	US7622572 AXMI-028 and AXMI-029, a family of novel delta-endotoxin genes and methods for their use
11/24/2009	US7622565 Nucleotide sequences comprising nucleotide sequences coding immune response modulator; immunotherapeutics; immunodiagnostics
11/24/2009	US7622561 IL-21 production in prokaryotic hosts
11/24/2009	US7622555 a novel protein (INSP052), identified as an immunoglobulin domain-containing cell surface recognition molecule and to the use of this proteins and nucleic acid sequences from the encoding gene in the diagnosis, prevention and treatment of disease
11/24/2009	US7622457 Polynucleotides encoding anticoagulant fusion proteins
11/24/2009	US7622442 Interacting the immature dendritic cells with an antigen ex vivo so that the surface antigen is presented; inducing maturation ex vivo; and contacting with a modulator comprising TRANCE; an increased viability relative to a control dendritic cell not contacted with TRANCE
11/24/2009	US7622300 Trans-lentiviral vector particles and transduction of eukaryotic cells therewith
11/24/2009	US7622292 Regulation of human transmembrane serine protease
11/24/2009	US7622289 Ornithine aminotransferase (OAT): a target for anticancer drugs
11/24/2009	US7622287 Myceliophthora thermophila laccase variants
11/24/2009	US7622280 Silicone based surfactant comprising hydrophobic and hydrophilic phases containing functional in vitro eukaryotic expression systems; compartmentalisation of transcription/translation reactions
11/24/2009	US7622248 Providing a ribozyme capable of aminoacylating tRNA with a non-cognate amino acid, providing tRNA and a non-cognate amino acid for tRNA, combining to effect aminoacylation of tRNA with non-cognate amino acid
11/24/2009	US7622122 Oxidative damage and protease activity resistance; catalytic efficiency; deep vein thrombosis, disseminated intravascular coagulation, acute coronary syndrome; targeting protein, that interacts with tissue factor or the factor VIIa/tissue factor complex
11/24/2009	US7622119 Wilm's tumor amino acid sequences for use as tissue targeted agent for treatment of cell proliferative disorders
11/24/2009	US7622116 Method of treating inflammation using soluble IL-17RCX4
11/24/2009	US7622112 Anti-SARS monoclonal antibodies
11/24/2009	US7622106 Necrosis assay
11/24/2009	CA2474880C Production of hybridoma producing antihuman cenp-a peptide monoclonal antibody and method of using the same
11/24/2009	CA2374513C Il-1 eta dna and polypeptides
11/24/2009	CA2321938C Poly zinc finger proteins with improved linkers
11/24/2009	CA2303063C Mage-3 peptides presented by hla class ii molecules
11/24/2009	CA2200693C Gp 130 lacking the transmembrane domain
11/19/2009	WO2009139464A1 Pharmaceutical composition for treatment of dry eye and/or corneal/conjunctival disorders
11/19/2009	WO2009139392A1 PROCESS FOR PRODUCTION OF β-ALANYLAMINO ACID OR DERIVATIVE THEREOF
11/19/2009	WO2009137934A1 Oilseed protein concentrates and isolates, and processes for the production thereof
11/19/2009	WO2008129422A8 Demannosylated recombinant factor viii for the treatment of patients with haemophilia a
11/19/2009	US20090288225 Novel Aromatic Acyltransferase Genes
11/19/2009	US20090288219 Method of Production of Recombinant Sucrose Synthase, Use Thereof in the Manufacture of Kits for Determination of Sucrose, Production of Adpglucose and Production of Transgenic Plants Whose Leaves and Storage Organs Accumulate High Contents of Adpglucose and Starch
11/19/2009	US20090288180 Novel protein and production process and use thereof

1 ... 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 ... 1125